Results summary | View all lists in L2L MDB | View all genes in L01A.profile.ud50 |
Up-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 14.62-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
221577_X_AT | GDF15 | C | S | growth differentiation factor 15 | |||||||||
202284_S_AT | CDKN1A | G | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||||||||||
202922_AT | GCLC | G | X | E | R | glutamate-cysteine ligase, catalytic subunit | |||||||
209160_AT | AKR1C3 | E | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | ||||||||||
219475_AT | OSGIN1 | D | oxidative stress induced growth inhibitor 1 | ||||||||||
203925_AT | GCLM | X | E | glutamate-cysteine ligase, modifier subunit |